ES542565A0 - Un procedimiento para la preparacion de nuevas ocfidrotiazolo (4,5-g) guinolinas. - Google Patents
Un procedimiento para la preparacion de nuevas ocfidrotiazolo (4,5-g) guinolinas.Info
- Publication number
- ES542565A0 ES542565A0 ES542565A ES542565A ES542565A0 ES 542565 A0 ES542565 A0 ES 542565A0 ES 542565 A ES542565 A ES 542565A ES 542565 A ES542565 A ES 542565A ES 542565 A0 ES542565 A0 ES 542565A0
- Authority
- ES
- Spain
- Prior art keywords
- sub
- alkyl
- ocfidrotiazolo
- guinolins
- procedure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 239000002253 acid Substances 0.000 abstract 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 2
- 150000003839 salts Chemical group 0.000 abstract 2
- 125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 abstract 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 abstract 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- 125000005037 alkyl phenyl group Chemical group 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 229940052760 dopamine agonists Drugs 0.000 abstract 1
- 239000003136 dopamine receptor stimulating agent Substances 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 abstract 1
- -1 substituted-octahydrothiazolo [4,5-g]quinolines Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
- C07D215/30—Metal salts; Chelates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Anesthesiology (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/604,687 US4537893A (en) | 1984-04-27 | 1984-04-27 | Octahydrothiazolo[4,5-g]quinolines and use as prolactin secretion inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES8704177A1 ES8704177A1 (es) | 1987-03-16 |
| ES542565A0 true ES542565A0 (es) | 1987-03-16 |
Family
ID=24420601
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES542565A Expired ES8704177A1 (es) | 1984-04-27 | 1985-04-25 | Un procedimiento para la preparacion de nuevas ocfidrotiazolo (4,5-g) guinolinas. |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US4537893A (es) |
| EP (1) | EP0160502B1 (es) |
| JP (1) | JPH0631262B2 (es) |
| KR (1) | KR870001072B1 (es) |
| CN (1) | CN85101547A (es) |
| AT (1) | ATE67767T1 (es) |
| AU (1) | AU564946B2 (es) |
| CA (1) | CA1287356C (es) |
| DE (1) | DE3584183D1 (es) |
| DK (1) | DK185485A (es) |
| ES (1) | ES8704177A1 (es) |
| GR (1) | GR850989B (es) |
| HU (1) | HU193113B (es) |
| IL (1) | IL74988A0 (es) |
| NZ (1) | NZ211863A (es) |
| PH (1) | PH21951A (es) |
| PT (1) | PT80339B (es) |
| SU (1) | SU1414318A3 (es) |
| ZA (1) | ZA852999B (es) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4778894A (en) * | 1983-09-26 | 1988-10-18 | Eli Lilly And Company | 6 oxo-decahydroquinolines |
| US4977160A (en) * | 1986-06-16 | 1990-12-11 | Eli Lilly And Company | BCD tricyclic ergoline part-structure analogues |
| US5134143A (en) * | 1986-06-16 | 1992-07-28 | Eli Lilly And Company | BCD tricyclic ergoline part-structure analogues |
| US4826986A (en) * | 1986-06-16 | 1989-05-02 | Eli Lilly And Company | 6-Oxo-trans-octa- and decahydroquinolines |
| DE3624607A1 (de) * | 1986-07-21 | 1988-01-28 | Boehringer Ingelheim Kg | Neue tetrahydrobenzothiazolo-chinoline ihre herstellung und verwendung |
| US4762843A (en) * | 1986-09-15 | 1988-08-09 | Warner-Lambert Company | Hetero [f] fused carbocyclic pyridines as dopaminergic agents |
| US5006525A (en) * | 1989-07-24 | 1991-04-09 | Eli Lilly And Company | Dopamine agonists method |
| US4939259A (en) * | 1989-07-24 | 1990-07-03 | Eli Lilly And Company | 2-oxo-pyrido[2,3-g]quinoline derivatives |
| US5057515A (en) * | 1989-07-24 | 1991-10-15 | Eli Lilly And Company | Method for agonizing a dopamine receptor |
| US4977149A (en) * | 1989-07-24 | 1990-12-11 | Eli Lilly And Company | Pyridoquinoline dopamine agonists, compositions and use |
| US5416090A (en) * | 1991-01-31 | 1995-05-16 | Eli Lilly And Company | Method of treating inflammation |
| CA2144669A1 (en) * | 1994-03-29 | 1995-09-30 | Kozo Akasaka | Biphenyl derivatives |
| EP0816406B1 (de) * | 1996-06-26 | 2000-09-06 | Bayer Ag | Verfahren zur Herstellung salzarmer Präparationen von Kondensationsprodukten |
| WO2009139855A2 (en) * | 2008-05-14 | 2009-11-19 | Ipsen Pharma S.A.S. | Pharmaceutical compositions of somatostatin-dopamine conjugates |
| TWI537274B (zh) * | 2011-03-14 | 2016-06-11 | 橘生藥品工業股份有限公司 | 新穎之八氫噻吩并喹啉衍生物、含有其之醫藥組成物及該等之用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2056224A1 (de) * | 1969-11-17 | 1971-06-03 | Danchi Seiyaku Co , Ltd , Tokio | Neue Thiazolochinohnderivate und Ver fahren zu ihrer Herstellung |
| US4198415A (en) * | 1979-01-22 | 1980-04-15 | Eli Lilly And Company | Prolactin inhibiting octahydro pyrazolo[3,4-g]quinolines |
| US4258049A (en) * | 1979-07-02 | 1981-03-24 | Smithkline Corporation | Inhibiting phenylethanolamine N-methyltransferase with thiadiazolo and oxadiazolotetrahydroisoquinolines |
| US4367231A (en) * | 1979-09-14 | 1983-01-04 | Eli Lilly And Company | Method of using octahydro pyrazolo[3,4-g]quinolines |
-
1984
- 1984-04-27 US US06/604,687 patent/US4537893A/en not_active Expired - Fee Related
-
1985
- 1985-04-01 CN CN198585101547A patent/CN85101547A/zh active Pending
- 1985-04-22 ZA ZA852999A patent/ZA852999B/xx unknown
- 1985-04-22 NZ NZ211863A patent/NZ211863A/en unknown
- 1985-04-22 CA CA000479702A patent/CA1287356C/en not_active Expired - Lifetime
- 1985-04-22 SU SU853883101A patent/SU1414318A3/ru active
- 1985-04-23 GR GR850989A patent/GR850989B/el unknown
- 1985-04-23 IL IL74988A patent/IL74988A0/xx unknown
- 1985-04-23 PT PT80339A patent/PT80339B/pt not_active IP Right Cessation
- 1985-04-24 AT AT85302852T patent/ATE67767T1/de not_active IP Right Cessation
- 1985-04-24 DE DE8585302852T patent/DE3584183D1/de not_active Expired - Lifetime
- 1985-04-24 AU AU41666/85A patent/AU564946B2/en not_active Ceased
- 1985-04-24 EP EP85302852A patent/EP0160502B1/en not_active Expired - Lifetime
- 1985-04-25 DK DK185485A patent/DK185485A/da not_active Application Discontinuation
- 1985-04-25 ES ES542565A patent/ES8704177A1/es not_active Expired
- 1985-04-25 PH PH32196A patent/PH21951A/en unknown
- 1985-04-25 KR KR1019850002803A patent/KR870001072B1/ko not_active Expired
- 1985-04-26 JP JP60092157A patent/JPH0631262B2/ja not_active Expired - Lifetime
- 1985-04-26 HU HU851624A patent/HU193113B/hu unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PH21951A (en) | 1988-04-15 |
| JPH0631262B2 (ja) | 1994-04-27 |
| US4537893A (en) | 1985-08-27 |
| ATE67767T1 (de) | 1991-10-15 |
| GR850989B (es) | 1985-11-25 |
| DK185485D0 (da) | 1985-04-25 |
| ES8704177A1 (es) | 1987-03-16 |
| JPS60233091A (ja) | 1985-11-19 |
| PT80339B (en) | 1987-02-16 |
| IL74988A0 (en) | 1985-08-30 |
| DK185485A (da) | 1985-10-28 |
| KR870001072B1 (ko) | 1987-05-27 |
| DE3584183D1 (de) | 1991-10-31 |
| HUT37624A (en) | 1986-01-23 |
| HU193113B (en) | 1987-08-28 |
| EP0160502A2 (en) | 1985-11-06 |
| EP0160502A3 (en) | 1987-03-11 |
| AU564946B2 (en) | 1987-09-03 |
| PT80339A (en) | 1985-05-01 |
| KR850007261A (ko) | 1985-12-02 |
| CN85101547A (zh) | 1987-01-24 |
| SU1414318A3 (ru) | 1988-07-30 |
| CA1287356C (en) | 1991-08-06 |
| ZA852999B (en) | 1986-11-26 |
| AU4166685A (en) | 1985-10-31 |
| NZ211863A (en) | 1987-10-30 |
| EP0160502B1 (en) | 1991-09-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3584183D1 (de) | Octahydrothiazolo(4,5-g)chinoline. | |
| KR830005187A (ko) | 아미노사이클로펜탄 알케노산 및 에스테르의 제조방법 | |
| ES541557A0 (es) | Un procedimiento para la preparacion de nuevos derivados de 8-cloro-1,5-benzotiazepina | |
| DE3687288D1 (de) | Chinuclidinderivate. | |
| KR850001171A (ko) | 퀴놀린 화합물의 제조방법 | |
| ES8406440A1 (es) | Procedimiento para preparar derivados de 2-amino-3-acilamino-6-bencilamino-piridina | |
| ES8604547A1 (es) | Procedimiento para preparar nuevos derivados de acidos feni-laceticos | |
| SE8302347L (sv) | Bensoazacykloalkyl-spiro-imidazolidiner, framstellning derav och farmaceutiska kompositioner innehallande dem | |
| ES8601201A1 (es) | Procedimiento para preparar derivados de imidazolina | |
| ES529069A0 (es) | Procedimiento de preparar nuevos derivados de sales inertes de hidroxido de aminopiridinio y sus sales correspondientes | |
| KR840004422A (ko) | 사이프로헵타딘-3-카복실산의 에스테르 및 관련 화합물의 제조방법 | |
| ES533320A0 (es) | Procedimiento para preparar 1-acetonil-2-(fenilimino)-imidazolidinas | |
| ES8308325A1 (es) | "procedimiento para la preparacion de benzotriazoles". | |
| ES515106A0 (es) | "procedimiento para la preparacion de compuestos de 1-fenilindazol-3-ona". | |
| ES8106517A1 (es) | Procedimiento para la preparacion de nuevos derivados de 10-halogen-e-homo-eburnanos. | |
| KR860001815A (ko) | 옥타하이드로-옥사졸로[4,5-g]퀴놀린의 제조방법 | |
| ES8500924A1 (es) | Procedimiento para la preparacion de derivados de acido fenilacetico | |
| DK469285A (da) | Thiadiazolderivater, der indvirker paa centralnervesystemet, fremgangsmaade til fremstilling deraf og midler indeholdende derivaterne | |
| AU2508584A (en) | N-arylpiperazine derivatives | |
| KR850004760A (ko) | 이미다조 퀴놀린 유도체의 제조방법 | |
| ES2007339A6 (es) | Procedimiento para preparar nueevos derivados de ergoleno halogenados. | |
| RU95117134A (ru) | Производное морфолина или его фармацевтически приемлемая соль и фармацевтическая композиция на его основе | |
| ES8607331A1 (es) | Procedimiento para preparar derivados de oxazafosforina | |
| RU94012551A (ru) | Бензамидные производные, способы их получения, фармацевтическая композиция и способ лечения | |
| KR850002479A (ko) | 피리미도 [4,5-g] 퀴놀린 유도체의 제조방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD1A | Patent lapsed |
Effective date: 19970612 |